The Risk of Acquiring Hepatitis A and B Among Travelers in Selected Eastern and Southern Europe and Non‐European Mediterranean Countries: Review and Consensus Statement on Hepatitis A and B Vaccination

Le résumé fourni par la source

Large numbers of Europeans travel frequently to destinations both near and far, and there is a growing trend toward shorter but more frequent trips.1 Traditional destinations for European (EU) travelers, such as France, Italy, and Spain, have shown only limited tourism growth in recent years, with these countries experiencing growth of 2.4, 0.6, and 3.3%, respectively, in 2000 to 2001. Many more Europeans now visit non‐EU Mediterranean destinations, for example, Morocco, Egypt, and Turkey (which experienced growth of 17, 49, and 29%, respectively, in 2004), and newly emerging travel destinations in Eastern and Southern Europe, for example, Croatia (which experienced growth of 6% in 2004).2 Importantly, travel to such destinations is not generally perceived as a potential health risk3 in the same way as travel to more “exotic” destinations (eg, Thailand, Mexico). Many Europeans traveling to Turkey or to North Africa, for example, do not consider themselves to be at major risk of infection with the hepatitis A virus (HAV) or hepatitis B virus (HBV).4,5

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.